Evidence map›Paper›PMID 32705976›Full record

ReviewThe American journal of tropical medicine and hygiene2020

Paulin M Kapepula, Jimmy K Kabengele, Micheline Kingombe, Françoise Van Bambeke, Paul M Tulkens, Antoine Sadiki Kishabongo, Eric Decloedt, Adam Zumla, Simon Tiberi, Fatima Suleman and 4 more

Erratum issuedOpen access · hybridAbstract readReview
In one paragraph

Review in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Selected Cannabinoids, Cannabimimetic Agents andPharmaceuticals (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Anti-COVID-19 potential ofScientific African · 2022
    Review
  13. Molecules (Basel, Switzerland) · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 5 countries.

Paulin M Kapepula1Faculty of Pharmaceutical Sciences, Centre d'Etudes des Substances Naturelles d'Origine Végétale (CESNOV), University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Jimmy K Kabengele1Faculty of Pharmaceutical Sciences, Centre d'Etudes des Substances Naturelles d'Origine Végétale (CESNOV), University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Micheline Kingombe2National Program for the Promotion of Traditional Medicine and Medicinal Plants (PNMT-PM), Ministry of Public Health, Kinshasa, Democratic Republic of Congo.
Françoise Van Bambeke3Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
Paul M Tulkens3Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
Antoine Sadiki Kishabongo4Department of Clinical Biology, Université Catholique de Bukavu (UCB), Bukavu, Democratic Republic of the Congo.
Eric Decloedt5Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Adam Zumla6Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Simon Tiberi6Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Fatima Suleman7Pharmaceutical Sciences, University of KwaZulu Natal, Durban, South Africa.
Léon Tshilolo8Unit of Sickle Cell Disease and Clinical Research, Monkole Hospital Center, Kinshasa, Democratic Republic of Congo.
Jean-Jacques Muyembe-TamFum11National Institute of Biomedical Research (INRB), Kinshasa, Democratic Republic of Congo.
Alimuddin Zumla13Division of Infection and Immunity, Department of Infection, Centre for Clinical Microbiology, University College London, London, United Kingdom.
Jean B Nachega15Department of Medicine and Centre for Infectious Diseases, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Queen Mary University of London · GBUniversity of Kinshasa · CDUCLouvain · BEJohns Hopkins University · USMinistry of Public Health · CDStellenbosch University · ZAUniversité Catholique de Bukavu · CDUniversity of KwaZulu-Natal · ZAUniversity of Mbuji Mayi · CD

Funding

Stellenbosch University Clinical Trial Unit, Cape Town, South AfricaU01AI069521 · NIAID · STELLENBOSCH UNIVERSITY · PI COTTON, MARK FREDRIC · 2007 to 2011
$8.4M
African Association for Health Professions Education and ResearchR25TW011217 · FIC · INFECTIOUS DISEASES INSTITUTE · PI ADEJUMO, PRISCA, NACHEGA, JEAN BISIMWA · 2018 to 2023
$3.9M
Developing Research Innovation, Localization and Leadership in South Africa (DRILL)D43TW010131 · FIC · UNIVERSITY OF KWAZULU-NATAL · PI BRYSIEWICZ, PETRA, MOSHABELA, MOSA · 2015 to 2019
$3.2M
University of Pittsburgh HIV-Comorbidities Research Training Program in South AfricaD43TW010937 · FIC · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NACHEGA, JEAN BISIMWA, SEEDAT, SORAYA · 2019 to 2023
$1.2M
FIC NIH HHS D43 TW010131FIC NIH HHS D43 TW010937FIC NIH HHS R25 TW011217NIAID NIH HHS U01 AI069521
6 · The paper itself

Abstract

The world is currently facing a novel COVID-19 pandemic caused by SARS-CoV-2 that, as of July 12, 2020, has caused a reported 12,322,395 cases and 556,335 deaths. To date, only two treatments, remdesivir and dexamethasone, have demonstrated clinical efficacy through randomized controlled trials (RCTs) in seriously ill patients. The search for new or repurposed drugs for treatment of COVID-19 continues. We have witnessed anecdotal use of herbal medicines, including

Indexed as

ArtemisiaBetacoronavirusRandomized Controlled Trials as TopicCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentHumansPandemicsPlant ExtractsPneumonia, ViralSARS-CoV-2Plant Extracts

Identifiers

PMID32705976
PMCPMC7470522
OpenAlexW3045033308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.